Greenlight Capital funds returned -3.6% in Q3 2025, net of fees and expenses, compared to 8.1% for the S&P 500 index, ...
The hedge fund called out a small investment in biotech Coya Therapeutics (COYA), which has just begun clinical trials for a treatment of Lou Gehrig's disease. Greenlight, which is Coya's largest ...
Q3 2025 Earnings Call October 22, 2025 5:30 PM EDTCompany ParticipantsTravis Axelrod - Head of Investor RelationsElon Musk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback